Cytek Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
202.96 |
197.88 |
213.48 |
243.94 |
317.00 |
| Przychód Δ r/r |
0.00% |
-2.50% |
7.88% |
14.27% |
29.95% |
| Przychód (min) |
196.92 |
194.28 |
200.61 |
243.88 |
307.57 |
| Przychód (max) |
207.22 |
199.88 |
222.89 |
244.00 |
323.66 |
| EBITDA (średnia) |
9.42 |
9.18 |
9.91 |
11.32 |
14.71 |
| EBIT (średnia) |
3.28 |
3.20 |
3.45 |
3.95 |
5.13 |
| EBIT % |
1.62% |
1.62% |
1.62% |
1.62% |
1.62% |
| Zysk netto (średni) |
20.90 |
-18.02 |
-8.88 |
3.51 |
31.35 |
| Zysk netto % |
10.30% |
-9.11% |
-4.16% |
1.44% |
9.89% |
| EPS (średnia) |
0.15 |
-0.14 |
-0.07 |
0.03 |
0.24 |
| Liczba analityków (Przychody) |
4 |
4 |
5 |
3 |
1 |
| Liczba analityków (EPS) |
3 |
2 |
3 |
2 |
1 |
| symbol |
CTKB |
CTKB |
CTKB |
CTKB |
CTKB |